Immune checkpoint blockade in infectious diseases

MN Wykes, SR Lewin - Nature Reviews Immunology, 2018 - nature.com
The upregulation of immune checkpoint molecules, such as programmed cell death protein
1 (PD1) and cytotoxic T lymphocyte antigen 4 (CTLA4), on immune cells occurs during acute …

T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses

A Saeidi, K Zandi, YY Cheok, H Saeidi… - Frontiers in …, 2018 - frontiersin.org
T-cell exhaustion is a phenomenon of dysfunction or physical elimination of antigen-specific
T cells reported in human immunodeficiency virus (HIV), hepatitis B virus (HBV), and …

TIGIT marks exhausted T cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection

GM Chew, T Fujita, GM Webb, BJ Burwitz, HL Wu… - PLoS …, 2016 - journals.plos.org
HIV infection induces phenotypic and functional changes to CD8+ T cells defined by the
coordinated upregulation of a series of negative checkpoint receptors that eventually result …

Immune activation and HIV persistence: implications for curative approaches to HIV infection

NR Klatt, N Chomont, DC Douek… - Immunological …, 2013 - Wiley Online Library
Despite complete or near‐complete suppression of human immunodeficiency virus (HIV)
replication with combination antiretroviral therapy, both HIV and chronic …

[HTML][HTML] Costimulatory and coinhibitory receptor pathways in infectious disease

J Attanasio, EJ Wherry - Immunity, 2016 - cell.com
Costimulatory and inhibitory receptors play a key role in regulating immune responses to
infections. Recent translation of knowledge about inhibitory receptors such as CTLA-4 and …

Type I interferons in viral control and immune regulation

JR Teijaro - Current opinion in virology, 2016 - Elsevier
Highlights•IFN-I signaling has recently been shown to contribute to viral immune
pathologies.•Elevated IFN-I signatures are found in persistent virus infections in multiple …

Microbial translocation and microbiome dysbiosis in HIV-associated immune activation

AS Zevin, L McKinnon, A Burgener… - Current Opinion in HIV …, 2016 - journals.lww.com
Microbial translocation and microbiome dysbiosis in HIV-asso... : Current Opinion in HIV and
AIDS Microbial translocation and microbiome dysbiosis in HIV-associated immune activation …

Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy

CL Gay, RJ Bosch, J Ritz, JM Hataye… - The Journal of …, 2017 - academic.oup.com
Background. Reversing immune exhaustion with an anti-PD-L1 antibody may improve
human immunodeficiency virus type 1 (HIV-1)–specific immunity and increase clearance of …

Microbial translocation, immune activation, and HIV disease

NR Klatt, NT Funderburg, JM Brenchley - Trends in microbiology, 2013 - cell.com
The advent of combination antiretroviral therapy (cART) has significantly improved the
prognosis of human immunodeficiency virus (HIV)-infected individuals. However, individuals …

PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques

KD Kauffman, S Sakai, NE Lora, S Namasivayam… - Science …, 2021 - science.org
Boosting immune cell function by targeting the coinhibitory receptor PD-1 may have
applications in the treatment of chronic infections. Here, we examine the role of PD-1 during …